{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:03:18Z","timestamp":1789473798474,"version":"build-2803163510"},"reference-count":61,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Atopic dermatitis (AD) is a chronic inflammatory skin disease associated with excessive inflammation and defective skin barrier function. Activated protein C (APC) is a natural anticoagulant with anti-inflammatory and barrier protective functions. However, the effect of APC on AD and its engagement with protease activated receptor (PAR)1 and PAR2 are unknown. Methods: Contact hypersensitivity (CHS), a model for human AD, was induced in PAR1 knockout (KO), PAR2KO and matched wild type (WT) mice using 2,4-dinitrofluorobenzene (DNFB). Recombinant human APC was administered into these mice as preventative or therapeutic treatment. The effect of APC and PAR1KO or PARKO on CHS was assessed via measurement of ear thickness, skin histologic changes, inflammatory cytokine levels, Th cell phenotypes and keratinocyte function. Results: Compared to WT, PAR2KO but not PAR1KO mice displayed less severe CHS when assessed by ear thickness; PAR1KO CHS skin had less mast cells, lower levels of IFN-\u03b3, IL-4, IL-17 and IL-22, and higher levels of IL-1\u03b2, IL-6 and TGF-\u03b21, whereas PAR2KO CHS skin only contained lower levels of IL-22 and IgE. Both PAR1KO and PAR2KO spleen cells had less Th1\/Th17\/Th22\/Treg cells. In normal skin, PAR1 was present at the stratum granulosum and spinosum, whereas PAR2 at the upper layers of the epidermis. In CHS, however, the expression of PAR1 and PAR2 were increased and spread to the whole epidermis. In vitro, compared to WT cells, PAR1KO keratinocytes grew much slower, had a lower survival rate and higher para permeability, while PAR2KO cells grew faster, were resistant to apoptosis and para permeability. APC inhibited CHS as a therapeutic but not as a preventative treatment only in WT and PAR1KO mice. APC therapy reduced skin inflammation, suppressed epidermal PAR2 expression, promoted keratinocyte growth, survival, and barrier function in both WT and PAR1KO cells, but not in PAR2KO cells. Conclusions: APC therapy can mitigate CHS. Although APC acts through both PAR1 and PAR2 to regulate Th and mast cells, suppression of clinical disease in mice is achieved mainly via inhibition of PAR2 alone. Thus, APC may confer broad therapeutic benefits as a disease-modifying treatment for AD.<\/jats:p>","DOI":"10.3390\/ijms23010516","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T01:15:26Z","timestamp":1641518126000},"page":"516","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Activated Protein C Protects against Murine Contact Dermatitis by Suppressing Protease-Activated Receptor 2"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8563-7216","authenticated-orcid":false,"given":"Meilang","family":"Xue","sequence":"first","affiliation":[{"name":"Sutton Arthritis Research Laboratory, Institute of Bone and Joint Research, Kolling Institute, Faculty of Medicine and Health, University of Sydney at Royal North Shore Hospital, St Leonards, NSW 2065, Australia"},{"name":"The Australian Arthritis and Autoimmune Biobank Collaborative (A3BC), Institute of Bone and Joint Research, Kolling Institute, Faculty of Medicine and Health, University of Sydney at Royal North Shore Hospital, St Leonards, NSW 2065, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Lin","sequence":"additional","affiliation":[{"name":"Sutton Arthritis Research Laboratory, Institute of Bone and Joint Research, Kolling Institute, Faculty of Medicine and Health, University of Sydney at Royal North Shore Hospital, St Leonards, NSW 2065, Australia"},{"name":"The Australian Arthritis and Autoimmune Biobank Collaborative (A3BC), Institute of Bone and Joint Research, Kolling Institute, Faculty of Medicine and Health, University of Sydney at Royal North Shore Hospital, St Leonards, NSW 2065, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4610-4898","authenticated-orcid":false,"given":"Ruilong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Sutton Arthritis Research Laboratory, Institute of Bone and Joint Research, Kolling Institute, Faculty of Medicine and Health, University of Sydney at Royal North Shore Hospital, St Leonards, NSW 2065, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3671-8247","authenticated-orcid":false,"given":"Callum","family":"Fryer","sequence":"additional","affiliation":[{"name":"Sutton Arthritis Research Laboratory, Institute of Bone and Joint Research, Kolling Institute, Faculty of Medicine and Health, University of Sydney at Royal North Shore Hospital, St Leonards, NSW 2065, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn","family":"March","sequence":"additional","affiliation":[{"name":"The Australian Arthritis and Autoimmune Biobank Collaborative (A3BC), Institute of Bone and Joint Research, Kolling Institute, Faculty of Medicine and Health, University of Sydney at Royal North Shore Hospital, St Leonards, NSW 2065, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Jackson","sequence":"additional","affiliation":[{"name":"Sutton Arthritis Research Laboratory, Institute of Bone and Joint Research, Kolling Institute, Faculty of Medicine and Health, University of Sydney at Royal North Shore Hospital, St Leonards, NSW 2065, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/ced.13885","article-title":"What\u2019s new in atopic eczema? An analysis of systematic reviews published in 2016. Part 2: Epidemiology, aetiology and risk factors","volume":"44","author":"Solman","year":"2019","journal-title":"Clin. Exp. Derm."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mcna.2019.08.012","article-title":"Allergic Contact Dermatitis","volume":"104","author":"Nassau","year":"2020","journal-title":"Med. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI66125","article-title":"PAR-1 contributes to the innate immune response during viral infection","volume":"123","author":"Antoniak","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","article-title":"Progressive activation of T(H)2\/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis","volume":"130","author":"Gittler","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jaci.2017.01.009","article-title":"Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines","volume":"139","author":"Eichenfield","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00281-011-0284-6","article-title":"Protein C anticoagulant system\u2013Anti-inflammatory effects","volume":"34","author":"Esmon","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1182\/blood-2006-07-037945","article-title":"Acute inflammation is exacerbated in mice genetically predisposed to a severe protein C deficiency","volume":"109","author":"Lay","year":"2007","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1182\/blood-2015-02-355974","article-title":"Activated protein C: Biased for translation","volume":"125","author":"Griffin","year":"2015","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood-2003-06-1980","article-title":"Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice","volume":"103","author":"Yuda","year":"2004","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1183\/13993003.00459-2015","article-title":"Activated protein C inhibits neutrophil migration in allergic asthma: A randomised trial","volume":"46","author":"Berger","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"16356","DOI":"10.1074\/jbc.M111.325951","article-title":"Activated protein C inhibits pancreatic islet inflammation, stimulates T regulatory cells and prevents diabetes in NOD mice","volume":"287","author":"Xue","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.1071699","article-title":"Activation of endothelial cell protease activated receptor 1 by the protein C pathway","volume":"296","author":"Riewald","year":"2002","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"L368","DOI":"10.1152\/ajplung.00036.2007","article-title":"Role of PAR2 in murine pulmonary pseudomonal infection","volume":"294","author":"Moraes","year":"2008","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1093\/rheumatology\/keaa701","article-title":"Deficiency of protease-activated receptor (PAR) 1 and PAR2 exacerbates collagen-induced arthritis in mice via differing mechanisms","volume":"60","author":"Xue","year":"2021","journal-title":"Rheumatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s004030000168","article-title":"Distribution and potential biologic function of the thrombin receptor PAR-1 on human keratinocytes","volume":"292","author":"Algermissen","year":"2000","journal-title":"Arch.Dermatol.Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1600-0625.1999.tb00383.x","article-title":"Proteinase-activated receptor-2 in human skin: Tissue distribution and activation of keratinocytes by mast cell tryptase","volume":"8","author":"Steinhoff","year":"1999","journal-title":"Exp. Derm."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.0022-202X.2005.23952.x","article-title":"Endothelial protein C receptor and protease-activated receptor-1 mediate induction of a wound-healing phenotype in human keratinocytes by activated protein C","volume":"125","author":"Xue","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2119\/molmed.2014.00027","article-title":"Protease activated receptor-1 deficiency diminishes bleomycin-induced skin fibrosis","volume":"20","author":"Duitman","year":"2014","journal-title":"Mol. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ncomms1162","article-title":"PAR2 absence completely rescues inflammation and ichthyosis caused by altered CAP1\/Prss8 expression in mouse skin","volume":"2","author":"Frateschi","year":"2011","journal-title":"Nat. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1254\/jphs.08332FP","article-title":"Involvement of Tryptase and Proteinase-Activated Receptor-2 in Spontaneous Itch-Associated Response in Mice With Atopy-like Dermatitis","volume":"109","author":"Tsujii","year":"2009","journal-title":"J. Pharmacol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.it.2007.09.001","article-title":"Protease-activated receptors: Novel PARtners in innate immunity","volume":"28","author":"Shpacovitch","year":"2007","journal-title":"Trends Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2353\/ajpath.2008.070161","article-title":"Acute modulations in permeability barrier function regulate epidermal cornification: Role of caspase-14 and the protease-activated receptor type 2","volume":"172","author":"Demerjian","year":"2008","journal-title":"Am. J. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3349\/ymj.2010.51.6.808","article-title":"Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis","volume":"51","author":"Lee","year":"2010","journal-title":"Yonsei Med. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1113\/jphysiol.2006.121111","article-title":"Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice","volume":"578","author":"Grant","year":"2007","journal-title":"J. Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jid.2018.08.019","article-title":"PAR2 Pepducin-Based Suppression of Inflammation and Itch in Atopic Dermatitis Models","volume":"139","author":"Barr","year":"2019","journal-title":"J. Investig. Derm."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1600-0625.2011.01395.x","article-title":"Extended DNFB-induced contact hypersensitivity models display characteristics of chronic inflammatory dermatoses","volume":"21","author":"Rose","year":"2012","journal-title":"Exp. Derm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1165\/rcmb.2010-0397OC","article-title":"Cytoprotective-selective Activated Protein C Attenuates P. aeruginosa-induced Lung Injury in Mice","volume":"45","author":"Bir","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/rheumatology\/key429","article-title":"Activated protein C targets immune cells and rheumatoid synovial fibroblasts to prevent inflammatory arthritis in mice","volume":"58","author":"Xue","year":"2019","journal-title":"Rheumatology"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Yang, G., Seok, J.K., Kang, H.C., Cho, Y.Y., Lee, H.S., and Lee, J.Y. (2020). Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082867"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1128\/IAI.01019-09","article-title":"Protease-activated receptor 2 has pivotal roles in cellular mechanisms involved in experimental periodontitis","volume":"78","author":"Wong","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1172\/JCI133159","article-title":"KLK6 expression in skin induces PAR1-mediated psoriasiform dermatitis and inflammatory joint disease","volume":"130","author":"Billi","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/exd.13336","article-title":"Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment","volume":"27","author":"Krueger","year":"2018","journal-title":"Exp. Derm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"101981","DOI":"10.1016\/j.isci.2020.101981","article-title":"PAR-1 signaling on macrophages is required for effective in vivo delayed-type hypersensitivity responses","volume":"24","author":"Wilkinson","year":"2021","journal-title":"iScience."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/cei.12005","article-title":"Local and systemic effects of co-stimulatory blockade using cytotoxic T lymphocyte antigen-4-immunoglobulin in dinitrofluorobenzene- and oxazolone-induced contact hypersensitivity in mice","volume":"171","author":"Christensen","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/MIB.0000000000001045","article-title":"Protease-activated receptor 1 plays a proinflammatory role in colitis by promoting Th17-related immunity","volume":"23","author":"Saeed","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e135849","DOI":"10.1172\/jci.insight.135849","article-title":"Arrestin domain containing 3 promotes Helicobacter pylori-associated gastritis by regulating protease-activated receptor 1","volume":"5","author":"Liu","year":"2020","journal-title":"JCI Insight"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/bph.12544","article-title":"Biased signalling and proteinase-activated receptors (PARs): Targeting inflammatory disease","volume":"171","author":"Hollenberg","year":"2014","journal-title":"Br. J. Pharm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1182\/blood-2012-08-452169","article-title":"Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46","volume":"120","author":"Mosnier","year":"2012","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"11104","DOI":"10.1073\/pnas.1831452100","article-title":"Proteinase-activated receptor 1 activation induces epithelial apoptosis and increases intestinal permeability","volume":"100","author":"Chin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.1074\/jbc.M110.181388","article-title":"Activated protein C enhances human keratinocyte barrier integrity via sequential activation of epidermal growth factor receptor and Tie2","volume":"286","author":"Xue","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fendo.2014.00067","article-title":"Biased signaling of protease-activated receptors","volume":"5","author":"Zhao","year":"2014","journal-title":"Front. Endocrinol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"27215","DOI":"10.1074\/jbc.M114.599712","article-title":"Cathepsin S causes inflammatory pain via biased agonism of PAR2 and TRPV4","volume":"289","author":"Zhao","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"34803","DOI":"10.1074\/jbc.M110.163642","article-title":"Factor X\/Xa elicits protective signaling responses in endothelial cells directly via PAR-2 and indirectly via endothelial protein C receptor-dependent recruitment of PAR-1","volume":"285","author":"Bae","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/jth.14641","article-title":"Cell type-specific mechanisms coupling protease-activated receptor-1 to infectious colitis pathogenesis","volume":"18","author":"Boucher","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-1-62703-227-8_21","article-title":"Induction of contact hypersensitivity in the mouse model","volume":"961","author":"Martin","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jaci.2020.02.030","article-title":"Shifting paradigms in the immunology of atopic dermatitis","volume":"145","author":"Hijnen","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jaci.2019.11.047","article-title":"Progression of acute-to-chronic atopic dermatitis is associated with quantitative rather than qualitative changes in cytokine responses","volume":"145","author":"Tsoi","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12016-011-8252-4","article-title":"IgE, mast cells, and eosinophils in atopic dermatitis","volume":"41","author":"Liu","year":"2011","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/exd.13407","article-title":"Mast cells are critical for the limitation of thrombin-induced skin inflammation","volume":"27","author":"Suender","year":"2018","journal-title":"Exp. Derm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2013.08.057","article-title":"The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch","volume":"155","author":"Wilson","year":"2013","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/exd.14030","article-title":"House dust mite-treated PAR2 over-expressor mouse: A novel model of atopic dermatitis","volume":"28","author":"Smith","year":"2019","journal-title":"Exp. Derm."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.0906-6705.2004.00159.x","article-title":"Trypsin induces epidermal proliferation and inflammation in murine skin","volume":"13","author":"Rogalski","year":"2004","journal-title":"Exp. Derm."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10517-006-0376-9","article-title":"Effect of activated protein C on secretory activity of rat peritoneal mast cells","volume":"142","author":"Makarova","year":"2006","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_54","first-page":"29","article-title":"Activated protein C modulates the proinflammatory activity of dendritic cells","volume":"8","author":"Matsumoto","year":"2015","journal-title":"J. Asthma Allergy"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1820182","DOI":"10.1155\/2019\/1820182","article-title":"Correlation of Blood FoxP3+ Regulatory T Cells and Disease Activity of Atopic Dermatitis","volume":"2019","author":"Li","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"13610","DOI":"10.1074\/jbc.M610740200","article-title":"Protein C is an autocrine growth factor for human skin keratinocytes","volume":"282","author":"Xue","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.3389\/fimmu.2020.01740","article-title":"Protease-Activated Receptor-2 Regulates Neuro-Epidermal Communication in Atopic Dermatitis","volume":"11","author":"Buhl","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41467-017-00169-4","article-title":"Activated protein C protects from GvHD via PAR2\/PAR3 signalling in regulatory T-cells","volume":"8","author":"Ranjan","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/jor.22726","article-title":"Activated protein C (APC) can increase bone anabolism via a protease-activated receptor (PAR)1\/2 dependent mechanism","volume":"32","author":"Shen","year":"2014","journal-title":"J. Orthop. Res. Off. Publ. Orthop. Res. Soc."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1096\/fj.11-201004","article-title":"An antagonist of human protease activated receptor-2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen-induced arthritis in rats","volume":"26","author":"Lohman","year":"2012","journal-title":"FASEB J."},{"key":"ref_61","first-page":"56027","article-title":"Isolation and Culture of Primary Mouse Keratinocytes from Neonatal and Adult Mouse Skin","volume":"125","author":"Li","year":"2017","journal-title":"J. Vis. Exp. JOVE"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/1\/516\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:26:50Z","timestamp":1760362010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/1\/516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,3]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["ijms23010516"],"URL":"https:\/\/doi.org\/10.3390\/ijms23010516","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,3]]}}}